Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma: a multicentre retrospective cohort study

Conclusions
Our data identified BMI and bone metastases as novel clinical biomarkers that were independently associated with ICI outcomes in mUC. External and prospective validation are warranted.

Source: BMJ Open - March 29, 2024 Category: General Medicine Authors: Labidi, S., Meti, N., Barua, R., Li, M., Riromar, J., Jiang, D. M., Fallah-Rad, N., Sridhar, S. S., Del Rincon, S. V., Pezo, R. C., Ferrario, C., Cheng, S., Sacher, A. G., Rose, A. A. N. Tags: Open access, Oncology Source Type: research